Refine by
Epilepsy Treatment Articles & Analysis
4 news found
CIRM grant awarded to accelerate clinical trial of NRTX-1001, a promising regenerative neuronal cell therapy in adults with drug-resistant seizures NRTX-1001 is the first human cell therapy candidate to enter clinical investigation for the treatment of epilepsy Neurona Therapeutics, a clinical-stage biotherapeutics company advancing regenerative cell ...
Regulatory Pathway and Drug Identification Number (DIN) There is strong evidence from preclinical trial results that CanaQuest’s modified formulation, in combination with its proprietary processing and delivery method, is also a very promising epilepsy treatment. The Company is collaborating with experienced parties to initiate the application process, ...
With a network of nearly 50 partners throughout the United States, the Foundation connects people to treatment, support and resources; leads advocacy efforts; funds innovative research and the training of specialists, and educates the public about epilepsy and seizure first aid. For more than five decades, the Epilepsy Foundation has shone a ...
Flowonix Medical, Inc. and Cerebral Therapeutics, Inc. announced today the successful implant of the fifth patient in the ADDRESS (Australian Direct Drug Administration for Refractory Epilepsy) trial. The jointly developed therapy features a micro-infusion device which tightly controls drug delivery to a region of the brain for patients with medically refractory ...